These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36774843)
1. Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans. Wang XB; Wang ML; Chu YJ; Zhou PP; Zhang XY; Zou J; Zuo LH; Shi YY; Kang J; Li B; Cheng WB; Sun Z; Zhang XJ; Du SZ Phytomedicine; 2023 Apr; 112():154709. PubMed ID: 36774843 [TBL] [Abstract][Full Text] [Related]
2. Identifying quality markers of Mailuoshutong pill against thromboangiitis obliterans based on chinmedomics strategy. Chu YJ; Wang ML; Wang XB; Zhang XY; Liu LW; Shi YY; Zuo LH; Du SZ; Kang J; Li B; Cheng WB; Sun Z; Zhang XJ Phytomedicine; 2022 Sep; 104():154313. PubMed ID: 35810519 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effect and mechanism of Mailuo Shutong Pills on posterior limb swelling caused by femur fracture in rats based on intestinal flora and intestinal metabolism]. Yang L; Liu MF; Sun CH; Xiang HX; Miao Y; Cheng GL Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4711-4721. PubMed ID: 37802810 [TBL] [Abstract][Full Text] [Related]
4. Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats. Zhang Z; Ji J; Zhang D; Ma M; Sun L Phytomedicine; 2020 Jan; 66():153110. PubMed ID: 31790900 [TBL] [Abstract][Full Text] [Related]
5. Integrated network pharmacology and metabolomics reveal vascular protective effects of Ilex pubescens on thromboangiitis obliterans. Chen J; Wang Y; Chen C; Song X; Shen X; Cao D; Zhao Z Phytomedicine; 2024 Jul; 130():155720. PubMed ID: 38763010 [TBL] [Abstract][Full Text] [Related]
6. Network pharmacology and experimental verification to explore the anti-superficial thrombophlebitis mechanism of Mailuo shutong pill. Li S; Xiao H; Liu M; Wang Q; Sun C; Yao J; Cao N; Zhang H; Zhang G; Xiao X J Ethnopharmacol; 2024 Mar; 322():117668. PubMed ID: 38159829 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics/pharmacometabolomics-pharmacodynamics reveals the synergistic mechanism of a multicomponent herbal formula, Baoyuan decoction against cardiac hypertrophy. Du Z; Lu Y; Sun J; Chang K; Lu M; Fang M; Zeng X; Zhang W; Song J; Guo X; Tu P; Jiang Y Biomed Pharmacother; 2021 Jul; 139():111665. PubMed ID: 34243607 [TBL] [Abstract][Full Text] [Related]
8. Integration of traditional Chinese medicine and nibble debridement and dressing method reduces thrombosis and inflammatory response in the treatment of thromboangiitis obliterans. Li J; Zhong J; Huang C; Guo J; Wang B Ann Transl Med; 2021 Sep; 9(18):1413. PubMed ID: 34733965 [TBL] [Abstract][Full Text] [Related]
9. Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1/RAGE/ NF-κB pathway. Liu C; Kong X; Wu X; Wang X; Guan H; Wang H; Wang L; Jin X; Yuan H Biochem Biophys Res Commun; 2018 Oct; 505(1):282-289. PubMed ID: 30245136 [TBL] [Abstract][Full Text] [Related]
10. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats. Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071 [TBL] [Abstract][Full Text] [Related]
11. Mailuoning oral liquid ameliorates vasculitis in thromboangiitis obliterans rats via inactivating cGAS-STING-IRF3 and TLR4-MAPKs/NF-κB signaling pathways. Fan L; Tang K; Li J; Tan Y; Liu X; Bai Z; Tao A; Tan N J Ethnopharmacol; 2024 Aug; 337(Pt 1):118707. PubMed ID: 39181282 [TBL] [Abstract][Full Text] [Related]
12. Protective Effects and Potential Mechanism of Tongxinluo on Mice with Thromboangiitis Obliterans Induced by Sodium Laurate. Gu JJ; Wei YR; Ma K; Wang XQ; Gao HL Chin J Integr Med; 2023 Jul; 29(7):608-616. PubMed ID: 36959433 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach. Li HY; Sun H; Zhang AH; He LW; Qiu S; Xue JR; Wu F; Wang XJ Front Pharmacol; 2022; 13():827733. PubMed ID: 35273504 [TBL] [Abstract][Full Text] [Related]
14. Si-Miao-Yong-An Decoction alleviates thromboangiitis obliterans by regulating miR-548j-5p/IL-17A signaling pathway. Chu C; Sun S; Zhang Z; Wu Q; Li H; Liang G; Miao X; Jiang H; Gao Y; Zhang Y; Wang B; Li X Chin J Nat Med; 2024 Jun; 22(6):541-553. PubMed ID: 38906601 [TBL] [Abstract][Full Text] [Related]
15. Herbal therapy treatment in thromboangiitis obliterans: a retrospective clinical study. Li G; Zefr C; Yang B; He C; Hafner F; Pang H Ann Palliat Med; 2020 Jul; 9(4):1696-1707. PubMed ID: 32692190 [TBL] [Abstract][Full Text] [Related]
16. Effect of bradykinin on rats with thromboangiitis obliterans through PI3K/Akt signaling pathway. Du YM; Du BH; Yang J; Zang S; Wang XP; Mao X; Zhang W; Jiang LP Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10169-10176. PubMed ID: 31799689 [TBL] [Abstract][Full Text] [Related]
17. Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways. Zou C; Liu L; Huang C; Hu S Front Pharmacol; 2022; 13():1018438. PubMed ID: 36304158 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of Shenfu injection on thromboangiitis obliterans model rats. Hong F; He C; Liu X; Tu G; Guo F; Yang S J Ethnopharmacol; 2011 Nov; 138(2):458-62. PubMed ID: 21982791 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO). Gao J; Huang L; Wang J Curr Vasc Pharmacol; 2021; 19(6):655-662. PubMed ID: 33461467 [TBL] [Abstract][Full Text] [Related]
20. Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Xu Y; Zhang R; Chen J; Zhang Q; Wang J; Hu J; Guan X; Jin L; Fu H; Gui B; Guo Y; Li S Br J Pharmacol; 2009 Aug; 157(8):1368-79. PubMed ID: 19572944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]